Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
COVID-19 VaccinE Response in Rheumatology Patients
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Baricitinib (LY3009104) in Children With COVID-19
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
- Status
- COMPLETED
- Phase
- PHASE2
A Multiple Dose Study of LY3502970 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3473329 in Healthy Japanese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Oral LOXO-338 in Patients With Advanced Blood Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Baricitinib in Sjogren's Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Single-Dose Study of LY3471851 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1